SXE staged a strong comeback in the 2H, delivering a solid full year result. There are opportunities across sectors, particularly resources, offset by project timing risks associated with COVID and labour constraints. On our numbers operating leverage means a 5% change to the ~$500M revenue guidance would impact EBITDA by ~10%. We like SXE’s diversification, balance sheet strength, and dividend, and retain our BUY call.
To access the full report please log in under the Client Area at the bottom of this page.
Argonaut’s Client Area allows you to view delayed share prices, access Argonaut’s wealth of Research as well as create custom portfolios and set up company watch lists.
If you would like to access our research please contact us to create an account.
